ENTITY
Panacea Biotec

Panacea Biotec (PNCB IN)

6
Analysis
Health Care • India
Panacea Biotec Limited operates a pharmaceutical company in India, which manufactures a variety of drugs that are distributed internationally. The Company's products are available in an assortment of forms, including tablets, capsules, dry powder injectables, vaccines, gels, and syrups. Pancea Biotec's key products include a Hepatitis B vaccine and drugs for diabetes management.
more
bullish•Alembic Ltd
•13 Nov 2025 04:30

Insider Activity: Who Bought Their Own Stock in October?

​October 2025 saw limited insider buying activity in large and small cap companies, with some purchases made by promoters in September but reported...

Logo
254 Views
Share
•29 Dec 2024 07:30

APAC Healthcare Weekly (Dec 29)- Wuxi AppTech, SK Bioscience, Kaken Pharma, Shionogi, Daiichi Sankyo

Wuxi AppTech is selling its US and UK-based cell and gene therapy unit. APAC healthcare companies continued their licensing activities. Approvals...

Logo
562 Views
Share
•10 Nov 2024 07:30

APAC Healthcare Weekly (Nov 10)- Alteogen, Santen Pharmaceutical, Beigene, Sun Pharmaceutical

​Alteogen partners with Daiichi Sankyo for Enhertu, Volpara secures $7.3M contract, Santen launches Rhopressa in South Korea, Sun Pharma's Leqselvi...

Logo
935 Views
Share
•10 Jul 2018 15:02

Para IV Winners and Losers - June 2018

This month’s Para IV developments suggest that there is likely to be benefit to Baxter International Inc (BAX US) on Premix Precedex (4mc/ml), Endo...

Logo
469 Views
Share
•22 Nov 2015 13:18

Profit from India's Rapidly Growing Biotechnology Industry

Now is a strategic time to focus on the upside potential of biotechnology companies in India, as India’s biotechnology industry is projected to...

Share
x